Reportedly, 7 of 16 PC cases (44%) displayed diffuse or focal Rb expression, eight of 15 PC cases (53%) showed diffuse loss or overexpression of p53, and 6 of 14 PC cases (43%) showed diffuse loss or overexpression of p16. This evidence concerns the gene CDKN2A and pachyonychia congenita.